Press Releases Nanoform Finland Oyj

Equities

NANOFH

FI4000330972

Delayed Nasdaq Helsinki Other stock markets 05:10:35 13/05/2024 pm IST			5-day change	1st Jan Change
1.948 ^EUR	+0.31%		-5.89%	+22.90%

11/04	Nanoform Finland to Deliver Nanomedicine Technology to Japan	MT
11/04	Nanoform Enters Exclusive Partnership with CBC to Bring Best-In-Class Nanomedicine Technology to Japan	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nanoformed High-Concentration Biologics Formulation for Subcutaneous Delivery Results to be Presented by Takeda at DDF Summit	07/05	AQ
Disclosure of Major Holdings under Law 163/2024	26/04	AQ
New shares of Nanoform registered with the trade register	25/04	AQ
Nanoform successfully completes new share issue raising EUR 15.4 million to invest in commercialization of nanoparticle enabled formulations for next generation medicines	25/04	AQ
Nanoform announces its intention to carry out a new share issue of approximately 7 million new shares to invest in commercialization of nanoparticle enabled formulations for next generation medicines	24/04	AQ
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc	16/04	AQ
Resolutions of Nanoform Finland Plc's Annual General Meeting on April 16, 2024	16/04	AQ
Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan	11/04	AQ
Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer	09/04	AQ
Nanoform Finland Plc: Certified Adviser change to Carnegie Investment Bank Ab	08/04	AQ
The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key individuals	26/03	AQ
Notice to the Annual General Meeting of NANOFORM FINLAND Plc	12/03	AQ
Share subscriptions based on Nanoform Finland Plc's stock options 2/2019 and 1/2020	12/03	AQ
Nanoform Finland Plc - Manager's transactions - Miguel Calado	06/03	AQ
Nanoform Finland Plc - Manager's transactions - Mads Laustsen	06/03	AQ
Nanoform Finland Plc - Manager's transactions - Albert Hæggström	06/03	AQ
Nanoform Finland Plc - Manager's transactions - Jeanne Thoma	06/03	AQ
Apalutamide Study Again Demonstrates the Advantages of Nanoforming Over Traditional Cancer Treatment Formulations	29/02	AQ
Strong momentum in Project Nanoenzalutamide	29/02	AQ
Invitation to Nanoform's Q4 and FY 2023 Report Presentation	16/02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Nanoform Finland Oyj

Equities

NANOFH

FI4000330972

Press Releases

Filters